Harry J Iland
7PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 17, 2025
Measurable residual disease intervention in AML: a new therapeutic horizon.Andrew H Wei, Harry J Iland, Courtney D DiNardo
|Jan 28, 2025
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL.Harry J Iland, John Reynolds, Alan V Boddy
|Aug 30, 2023
Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG.Sun Loo, Andrew W Roberts, Natasha S Anstee
|Mar 29, 2022
Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia.Zachary D Epstein-Peterson, Andriy Derkach, Susan Geyer
Pageof 2
Frequent Collaborators
4 joint publications
Andrew Wei
4 joint publications
John Reynolds
2 joint publications
Steven W Lane
1 joint publications
Zachary D Epstein-Peterson
1 joint publications
Andriy Derkach
1 joint publications
Krzysztof Mrózek
1 joint publications
Courtney D DiNardo
1 joint publications
Richard A Larson
1 joint publications
Nigel Russell
1 joint publications
Richard Dillon
